ArticleBritish journal of cancer2026

Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Elena Sophia Lindner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.